| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crispr Therapeutics AG (CRSP) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. CRSP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 255.5K | $13.82M | - | |
| Dir | 22.0K | $1.19M | - | |
| CFO | 19.5K | $1.05M | - | |
| Other | 19.4K | $1.05M | -3,786 | |
| Other | 17.0K | $919.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2026 | Patel Naimish | Chief Medical Officer | Sale+OE | 3,786 | $55.62 | $210,577.32 | -16.4% | - | - | |
| Mar 23, 2026 | Prasad Raju53 | Chief Financial Officer | Sale+OE | 3,708 | $46.78 | $173,460.24 | -19.2% | +15.4% | - | |
| Mar 23, 2026 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 10,020 | $46.78 | $468,735.60 | -3.8% | +15.4% | - | |
| Mar 23, 2026 | Kasinger James R.61 | General Counsel And Secretary | Sale+OE | 3,182 | $46.78 | $148,853.96 | -3.3% | +15.4% | - | |
| Mar 16, 2026 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 10,349 | $48.26 | $499,442.74 | -4.0% | +2.9% | - | |
| Mar 16, 2026 | Kasinger James R.61 | General Counsel And Secretary | Sale+OE | 3,450 | $48.26 | $166,497.00 | -3.6% | +2.9% | - | |
| Mar 16, 2026 | Prasad Raju53 | Chief Financial Officer | Sale+OE | 9,869 | $48.26 | $476,277.94 | -23.8% | +2.9% | - | |
| Mar 16, 2026 | Patel Naimish | Chief Medical Officer | Sale+OE | 3,150 | $48.26 | $152,019.00 | -19.3% | +2.9% | - | |
| Mar 11, 2026 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 9,798 | $52.80 | $517,334.40 | -4.0% | +3.1% | - | |
| Mar 11, 2026 | Kasinger James R.61 | General Counsel And Secretary | Sale+OE | 2,800 | $52.80 | $147,840.00 | -3.1% | +3.1% | - |